These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. Bousquet J; Hejjaoui A; Skassa-Brociek W; Guérin B; Maasch HJ; Dhivert H; Michel FB J Allergy Clin Immunol; 1987 Oct; 80(4):591-8. PubMed ID: 3668124 [TBL] [Abstract][Full Text] [Related]
27. [Comparison of 3 types of immunotherapy for treating grass pollen-induced allergic rhinitis]. Hébert J; Bédard PM Allerg Immunol (Paris); 1986 Sep; 18(7):19-23. PubMed ID: 3453720 [TBL] [Abstract][Full Text] [Related]
28. Immunotherapy in hay fever with two major allergens 19, 25 and partially purified extract of timothy grass pollen. A controlled double blind study. In vitro variables, season i. Osterballe O; Løwenstein H; Prahl P; Skov P; Weeke B Allergy; 1981 Apr; 36(3):183-99. PubMed ID: 7015911 [No Abstract] [Full Text] [Related]
29. Specific IgE and IgG antibody responses in children to timothy pollen components during immunotherapy. Nordvall SL; Renck B; Einarsson R Allergy; 1989 Aug; 44(6):380-4. PubMed ID: 2802111 [TBL] [Abstract][Full Text] [Related]
30. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783 [TBL] [Abstract][Full Text] [Related]
31. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [TBL] [Abstract][Full Text] [Related]
32. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects. Winther L; Malling HJ; Mosbech H Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446 [TBL] [Abstract][Full Text] [Related]
33. Phoenix sylvestris Roxb pollen allergy: a 2-year randomized controlled trial and follow-up study of immunotherapy in patients with seasonal allergy in an agricultural area of West Bengal, India. Chakraborty P; Roy I; Chatterjee S; Chanda S; Gupta-Bharracharya S J Investig Allergol Clin Immunol; 2006; 16(6):377-84. PubMed ID: 17153886 [TBL] [Abstract][Full Text] [Related]
34. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy. Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779 [TBL] [Abstract][Full Text] [Related]
35. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen. Martínez-Cañavate Burgos A; Torres-Borrego J; Molina Terán AB; Corzo JL; García BE; Rodríguez Pacheco R; Moreno Aguilar C; Dávila I Pediatr Allergy Immunol; 2018 Jun; 29(4):369-374. PubMed ID: 29369414 [TBL] [Abstract][Full Text] [Related]
36. IgE, IgG and patient-self tests during slow hyposensitization to grass pollen. Blair H; Ezeoke A; Hobbs JR Clin Allergy; 1975 Sep; 5(3):263-70. PubMed ID: 1182987 [TBL] [Abstract][Full Text] [Related]